Abstract
We investigated whether the functional involvement of α1-adrenergic receptors (α1-AR) in the effects induced by antidepressant drugs, desipramine, and milnacipran varies depending on the α1-AR subtype. First, using a mouse line with triple knockout (KO) of genes encoding all three α1-AR subtypes (ABD-KO) and autoradiographic analysis, we demonstrated that the inactivation of α1-AR did not affect the density of other types of adrenergic receptors, α2- and β-AR in the mouse brain. Subsequently, we utilized three mouse knockout lines with selective inactivation of the gene encoding a single α1-adrenergic receptor subtype (A-KO, B-KO, and D-KO). We analyzed the impact of these mutations on tissue levels of monoaminergic neurotransmitters in the hypothalamus. Next, we assessed how a specific mutation affects the long-term effects of desipramine and milnacipran in the selected brain regions of male and female mice at various molecular levels: mRNA expression of α1-AR subtypes, gene expression profiling, and activation of selected signaling proteins (ERK1/2, Akt, GSK3). The main finding is that the inactivation of the α1D subtype modulates at various molecular levels the long-term effects of desipramine or milnacipran in a sex-dependent manner. Our study revealed the functional diversity between α1-AR subtypes in the molecular mechanisms of antidepressants’ drug action.

This publication has 90 references indexed in Scilit: